Steele Lab, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
jain@steele.mgh.harvard.edu
Recent findings suggest that combined administration of the angiogenic factors Ang1 and VEGF may improve current therapeutic approaches for inducing formation of new blood vessels. However, many questions remain about the mechanisms of these factors.
